Stéphane Roux Selected Research

Stéphane Roux Research Topics

27	Neoplasms (Cancer) 01/2023 - 08/2011
5	Brain Neoplasms (Brain Tumor) 05/2021 - 12/2011
4	Gliosarcoma 03/2014 - 09/2013
3	Glioma (Gliomas) 05/2021 - 01/2014
2	Glioblastoma (Glioblastoma Multiforme) 06/2023 - 01/2023
2	Hyperthermia 11/2021 - 01/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2019
1	Lymphoid Leukemia 03/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Carcinoma (Carcinomatosis) 01/2018
1	Neutropenia 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Squamous Cell Carcinoma of Head and Neck 01/2013
1	Insulinoma 09/2011

13	GoldIBA 06/2023 - 02/2014
10	GadoliniumIBA 01/2023 - 12/2011
5	Radiation-Sensitizing AgentsIBA 09/2019 - 12/2011
2	CytokinesIBA 06/2023 - 11/2021
2	ferric oxide (iron oxide)IBA 11/2021 - 01/2020
2	AGuIXIBA 09/2019 - 01/2014
2	Peptides (Polypeptides)IBA 09/2013 - 08/2011
1	Temozolomide (Temodar)FDA LinkGeneric 06/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	AcidsIBA 03/2020
1	Docetaxel (Taxotere)FDA Link 12/2019
1	Coloring Agents (Dyes)IBA 09/2019
1	theasinensin AIBA 08/2019
1	lutetium Lu 177 dotatateIBA 03/2019
1	PlatinumIBA 01/2019
1	MetalsIBA 01/2019
1	Contrast MediaIBA 08/2018
1	IsotopesIBA 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 01/2018
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2016
1	cyclic arginine-glycine-aspartic acid peptideIBA 09/2013
1	Blood Glucose (Blood Sugar)IBA 09/2011
1	Neuropilin-1IBA 08/2011
1	Photosensitizing Agents (Photosensitizers)IBA 08/2011

9	Radiotherapy 06/2023 - 01/2014
7	Intravenous Injections 09/2019 - 07/2013
4	Precision Medicine 09/2019 - 01/2013
3	Photothermal Therapy 07/2022 - 01/2020
2	Immunotherapy 11/2021 - 01/2018
2	Therapeutics 01/2019 - 07/2013
1	Traction 05/2021
1	Image-Guided Radiotherapy 05/2021
1	Transplantation 09/2011
1	Photochemotherapy (Photodynamic Therapy) 08/2011